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Somatic mosaicism in neuronal precursor
cells mediated by L1 retrotransposition
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Revealing the mechanisms for neuronal somatic diversification remains a central challenge for understanding individual
differences in brain organization and function. Here we show that an engineered human LINE-1 (for long interspersed
nuclear element-1; also known as L1) element can retrotranspose in neuronal precursors derived from rat hippocampus
neural stem cells. The resulting retrotransposition events can alter the expression of neuronal genes, which, in turn, can
influence neuronal cell fate in vitro. We further show that retrotransposition of a human L1 in transgenic mice results in
neuronal somatic mosaicism. The molecular mechanism of action is probably mediated through Sox2, because a
decrease in Sox2 expression during the early stages of neuronal differentiation is correlated with increases in both L1
transcription and retrotransposition. Our data therefore indicate that neuronal genomes might not be static, but some
might be mosaic because of de novo L1 retrotransposition events.
Neural stem cells give rise to three main lineages: astrocytes, oligo-
dendrocytes and neurons. Most of the cells from these lineages are
generated during development, although many continue to be born
throughout life in the adult mammalian brain1–3. In addition to the
lineage decisions made by each cell type, many different types of cell
are generated within each lineage. For example, within the neuronal
lineage there are Purkinje, granule, pyramidal and basket cells,
among others. Diversity also exists between individual cells within
a cell type. Although incompletely understood, neuronal diversity is
assumed to be governed by a combination of genetic and environ-
mental factors4,5. By studying neurogenesis, one can examine early
fate choices between lineages, type differences within a lineage, and
diversity between individual neurons.
The glycosylated form of cystatin C (CCg) allows the propagation
of multipotent neural progenitor cells (NPCs) from either single cells
or polyclonal cell populations plated at low density in the presence of
fibroblast growth factor-2 (FGF-2). By examining the transcription
profiles generated from CCg-responsive NPCs, we discovered a class
of overexpressed transcripts corresponding to L1s.
L1s are abundant retrotransposons that comprise about 20% of
mammalian genomes6–8. Most L1s are retrotransposition-defective
because they are 5 0 truncated, contain internal rearrangements or
harbour mutations within their open reading frames9,10. However,
the average human genome is estimated to contain 80–100 retro-
transposition-competent L1s (RC-L1s), and about 10% of these
elements are classified as highly active or ‘hot’11. By comparison,
the mouse genome is estimated to contain at least 3,000 active
L1s12,13.
Here we show that an engineered human L1 harbouring a retro-
transposition indicator cassette can retrotranspose in adult rat NPCs
in vitro, and in the brains of transgenic mice in vivo. Retrotransposi-
tion events in rat NPCs can influence both neuronal gene expression
and differentiation in vitro. Retrotransposition events were detected
in both neurogenic and non-neurogenic areas of the adult mouse
brain, indicating that retrotransposition is not peculiar to mature
NPCs but also occurs during neuronal development. Expression
analyses indicate that Sox2 might act to repress L1 transcription in rat
adult hippocampus neural stem (HCN) cells. However, during
neuronal differentiation, a decrease in Sox2 expression is correlated
with a derepression of L1 transcription and an increase in L1
retrotransposition. These findings indicate that some neuronal
genomes might not be static and might be influenced by de novo
L1 retrotransposition events.
L1 transcripts are upregulated in CCg-responsive cells
CCg-responsive cells were isolated from heterogeneous HCN cells by
plating them at low density in conditioned medium containing CCg
(see Methods and Supplementary Methods for details). The resultant
cell lines were then subjected to a microarray analysis to identify
genes whose expression changed in response to culturing in CCg
(Supplementary Fig. S1a and Supplementary Table S1). Surprisingly,
a 1.5–2-fold enrichment of L1 transcripts in CCg-responsive cells
was observed (Supplementary Fig. S1b and Supplementary Table S2).
Semiquantitative reverse transcriptase polymerase chain reaction
(RT–PCR) verified that L1 transcripts are enriched in CCg-responsive
cells (Supplementary Fig. S1c).
Sox2 expression is inversely correlated with L1 promoter
We tested whether the promoter (that is, the 5 0 untranslated region
(UTR)) of a retrotransposition-competent human L1 could function
in rat NPCs. The human L1 5 0 UTR contains a YY1-binding site
that is required for proper transcriptional initiation14,15 as well as two
Sox-binding sites16 and a runt-domain transcription factor 3
(RUNX3)-binding site17. Sox proteins are expressed in a variety of
tissues, including brain and testis18, and Sox2 is expressed in
both embryonic stem cells and neural progenitor populations19.
We therefore tested the effects of Sox2 on the human L1 5 0 UTR in
HCN cells. Although Sox2 did not induce the expression of the
reporter gene driven by the wild-type L1 5 0 UTR, Sox2 overexpres-
sion stimulated the expression of the reporter gene driven by a
promoter that lacks the first 100 base pairs (bp) of the L1 5 0 UTR. The
same trend was observed when the L1 promoter was cloned in an
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antisense orientation with reference to the gene encoding luciferase
(Supplementary Fig. S2a). Taken together, these findings indicate
that factors that interact with the first 100 bp of the human L1 5
0
UTR
might be influenced by the Sox2 protein.
We next investigated the dynamics of L1 expression in HCN cells
during neuronal differentiation. Sox2 expression was decreased
during the first 24 h after the induction of differentiation and
remained low for the duration of the 4-day assay (Fig. 1a). In
contrast, L1 expression was stimulated up to tenfold during the
first 24 h after the induction of differentiation. It then decreased
steadily from day 2 to day 4, but its expression remained higher than
that observed in undifferentiated cells (day 0; Fig. 1b). As expected,
the neuron-specific synapsin promoter20 was induced gradually
during neuronal differentiation (Supplementary Fig. S2b).
Additional experiments showed that a short interfering RNA
(siRNA)-mediated 75% decrease in Sox2 protein in HCN cells led
to a sixfold increase in L1 expression (Fig. 1c), whereas mutation of
the Sox-binding sites in the L1 5
0
UTR abolished the observed
transcriptional repression by Sox2 protein (Fig. 1d). Last, chromatin
immunoprecipitation (ChIP) revealed that Sox2 is associated with
the endogenous rat L1 promoter in undifferentiated HCN cells
(cultured with FGF-2) but is no longer associated with the rat L1
promoter 4 days after the induction of neuronal differentiation by
FSK/RA (Fig. 1e). Consistently, histone deacetylase 1 (HDAC1) and
methylation of histone H3 at Lys 9 (K9) (both associated with
transcriptional silencing)21 were also present in undifferentiated
HCN cells, whereas acetylation of H3 at K9 and its methylation at
Lys 4 (K4) (associated with transcriptional activation) were present
only in differentiated cells (Fig. 1e). Together, these data indicate that
Sox2 represses L1 transcription in HCN cells and that a decrease in
Sox2 expression during neuronal differentiation is correlated with
chromatin remodelling, allowing a transient stimulation of L1
transcription.
Rat NPCs can support human L1 retrotransposition
HCN cells are a heterogeneous population composed of Sox2-
positive neural stem cells (NSCs) and Sox2-negative NPCs. To test
whether L1 can retrotranspose in HCN cells, we obtained L1
expression constructs harbouring a retrotransposition indicator
cassette in their respective 3 0 UTRs. The indicator cassette consists
of the gene encoding enhanced green fluorescence protein (EGFP) in
the opposite orientation to the L1 transcript, a heterologous pro-
moter (pCMV) and a polyadenylation signal (pA) (Fig. 2a). The
EGFP gene is interrupted by an intron (IVS2 of the g-globin gene) in
the same transcriptional orientation as the L1 transcript. This
arrangement ensures that EGFP-positive cells arise only when a
transcript initiated from the promoter driving L1 expression is
spliced, reverse-transcribed and integrated into chromosomal
DNA, thereby allowing expression of the retrotransposed EGFP
gene from the pCMV promoter22,23.
Primary cultures of fresh rat adult hippocampus-derived neural
progenitor (AHNP) cells, previously established HCN cells, rat
primary neurons and astrocytes derived from the hippocampus, rat
mesenchymal stem cells, rat fibroblasts, human CD34þ lymphocytes
and human HeLa cells were electroporated with either an active
L1 element (LRE3-EGFP) or a retrotransposition-defective L1
(JM111-EGFP) that contained two missense mutations in open
reading frame 1 (ORF1)22–24. Cells harbouring the L1 expression
constructs were selected by the addition of puromycin to the culture
medium, and puromycin-resistant cells were screened for EGFP
expression by flow cytometry. After 3 days, EGFP expression was
detected only in HeLa cells (1.50 ^ 0.25%; data not shown). After 7
days, EGFP expression was detected in HCN cells (0.75 ^ 0.07%)
and AHNP cells (1.50 ^ 0.50%). EGFP-positive cells were not
detected in any of the other cell lines, even after several passages
(Supplementary Fig. S3). PCR confirmed the presence of the retro-
transposed (that is, spliced) EGFP gene in HCN-positive cells;
sequencing of the PCR products confirmed the precise splicing of
the intron (Fig. 2b; data not shown). Thus we conclude that a subset
of cells present in the HCN and AHNP populations can support L1
retrotransposition.
To discriminate which kind of NPCs in the AHNP and HCN cell
populations (that is, neuronal or glial progenitors) can support
retrotransposition, individual EGFP-positive and EGFP-negative
puromycin-resistant cells were collected by fluorescence-activated
cell sorting (FACS) 7 days after electroporation. EGFP-positive cells
Figure 1 | L1 expression correlates with decreased Sox2 expression in HCN
cells. a, Sox2 promoter is downregulated during neuronal differentiation.
HCN cells were transfected with a luciferase reporter gene driven by the Sox2
promoter (day 0). The cells were then grown in N2 medium in the absence of
FGF-2 but with RA/FSK to stimulate neuronal differentiation (days 1–4).
b, HCN cells were treated as described in a and the expression of a luciferase
reporter gene driven by the L1 5 0 UTR was followed for 4 days. c, SiRNA
inactivation of Sox2 transcripts correlates with increased activity in the L1
5 0 UTR promoter region. HCN cells were transfected with a luciferase
reporter gene driven by a wild-type L1 promoter (control; white bar) in the
presence of irrelevant siRNAs (siRNA scramble; black bar) or siRNA against
the Sox2 mRNA (grey bar). Transfection of HCN cells with siRNAs against
Sox2 mRNA decreased Sox2 protein levels by about 75% (inset).
d, Mutations in the binding sites of Sox2 protein in the L1 5 0 UTR promoter
region (grey bar) increased the luciferase activity in comparison with the
intact L1 5 0 UTR (white bar) in HCN cells. Sox2 overexpression cannot
induce the wild-type L1 5 0 UTR luciferase activity (black bar) but can
activate the mutant L1 5 0 UTR (hatched bar). e, Recruitment of Sox2,
HDAC1 and histone H3 modification on the endogenous rat L1 promoter
region during neuronal differentiation by ChIP. Extracts of formaldehyde-
fixed HCN cells were precipitated with specific antibodies, either in
undifferentiated cells (FGF-2) or after induction to neuronal differentiation
(RA/FSK), and then analysed by PCR with primers for the L1 5 0 UTR. Sox2
and HDAC1 were associated with the rat L1 promoter in undifferentiated
cells only. Modifications of histone H3 associated with the L1 promoter
indicate a dynamic chromatin structure, from a transcriptional silencing
status (undifferentiated cells) to a transcriptional activation (neurons).
Antibodies specific for methylated K9 in H3 (Met-K9), but not antibodies
specific for methylated K4 (Met-K4) or acetylated K9 (Ac-H3), highly
precipitated the L1 5 0 UTR sequence from HCN cell extracts. In contrast,
antibodies specific for either Met-K4 or Ac-H3 precipitated the L1 5 0 UTR
from neuronal extracts only. Error bars show s.e.m.
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remained green during their first week in culture and often displayed
a differentiated morphology when compared with cells in the initial
HCN population (Fig. 2c, insets). However, EGFP expression was
reduced over time and only a few cells remained EGFP-positive
after 2 weeks in culture (Fig. 2c). Unexpectedly, all puromycin-
resistant EGFP-negative clones also yielded a PCR product that
corresponded in size to the retrotransposed EGFP gene (Fig. 2d).
This observation might represent an event after FACS; a truncation of
the 5
0
end or the retrotransposed EGFP gene might undergo
epigenetic silencing either during or soon after L1 retrotransposition
(see below).
Expression of EGFP in neuronal differentiation
To test whether clones harbouring L1 retrotransposition events
remained multipotent, we stimulated their differentiation into the
three main neural cell types: neurons, astrocytes and oligodendro-
cytes (see Methods for differentiation conditions). Despite contain-
ing a retrotransposed EGFP gene, all of the clones tested at the onset
of this experiment were EGFP-negative, either because they never
expressed the retrotransposed EGFP gene (‘negative clones’) or
because the retrotransposed EGFP gene was silenced during cultur-
ing in the presence of FGF-2 (‘positive clones’). Under strong
induction conditions, each clone tested was capable of undergoing
differentiation into the three neural cells types at a similar rate to
that of HCN cells (Supplementary Fig. S4a). Reactivation of the
retrotransposed EGFP gene could be detected only during neuronal
differentiation (Supplementary Fig. S4b). Time-lapse imaging
revealed that EGFP expression began as early as 2 h after the
induction of neuronal differentiation, indicating that it might
have resulted from alterations in chromatin structure rather
than new L1 retrotransposition events (Supplementary movie).
EGFP-positive cells were rarely detected after the induction of
astrocyte or oligodendrocyte differentiation, and they never co-
localized with astrocyte (Gfap) or oligodendrocyte (Rip) markers,
unlike the cells expressing the control CMV-driven EGFP cassette
(Supplementary Fig. S4c), indicating that expression of the retro-
transposed EGFP gene during neuronal differentiation in the ana-
lysed clones might be due to epigenetic modifications rather than to
Figure 2 | NPCs can support L1 retrotransposition. a, Diagram of the
L1-EGFP retrotransposition indicator construct. Retrotransposition-
competent human L1s contain a 5 0 UTR harbouring an internal
promoter14,15, two open reading frames (ORF1 and ORF2; blue arrows), and
a 3 0 UTR that ends in a poly(A) tail6,9. The EGFP retrotransposition
indicator cassette consists of a backward copy of an EGFP gene whose
expression is controlled by the CMV minimal promoter (pCMV) and the
thymidine kinase polyadenylation sequence (pA). The EGFP gene is also
interrupted by an intron that is in the same transcriptional orientation as the
L1. This arrangement ensures that EGFP expression will become activated
only on L1 retrotransposition (see the text for details)22,23. PCR primers
flanking the intron in the EGFP gene are indicated at the bottom. The splice
donor (SD) and splice acceptor (SA) sites of the intron are indicated. b, PCR
analysis of genomic DNA isolated from different cell populations transfected
with LRE3-EGFP. PCR was conducted with the primers shown in a. The
1,243-bp PCR product corresponds to the original L1 vector harbouring the
intron-containing EGFP indicator cassette. The 343-bp PCR product,
diagnostic for the loss of the intron, indicates a retrotransposition event
(lane 4). Lane M, molecular mass standards; lane 1, water; lane 2, positive
control for the EGFP gene lacking an intron; lane 3, positive control for the
EGFP gene containing the intron; lane 4, NPCs, 7 days after transfection;
lane 5, NPCs, 3 days after transfection; lane 6, mesenchymal stem cells, 7
days after transfection; lane 7, fibroblast cells, 7 days after transfection.
c, Despite containing a retrotransposed EGFP gene, cells that were initially
EGFP-positive can no longer express EGFP. d, Puromycin-resistant clones
that never expressed EGFP harbour L1 retrotransposition events, as
indicated by the presence of the 343-bp PCR product. Lane M, molecular
mass standards; lane 1, water; lane 2, EGFPþ clone; lane 3, EGFP2 clone.
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neural cell-type-specific differences in pCMV promoter specificity.
To gain insights into the kinds of chromatin alterations that could
be involved in EGFP gene reactivation during neuronal differen-
tiation, we treated the clones with either 500 ng ml21 5-azacytidine
(5-Aza; a demethylating agent) for 4 days or 1mM trichostatin A
(TsA; an inhibitor of histone deacetylation activity) for 1 day in N2
medium. Both treatments caused an increase in EGFP expression in
the different clones assayed. Moreover, immunostaining revealed
that most of the EGFP-positive cells (63% in the TsA treatment and
30% in the 5-Aza treatment) co-localized with Map2(a þ b) but not
with Gfap (Supplementary Fig. S4d–f), which is consistent with
recent reports showing that epigenetic modifications accompany
neuronal differentiation of NSCs21,25.
L1s can insert into neuronally expressed genes
We next used inverse PCR26 to characterize the post-integration sites
from 17 clones (independent of the initial EGFP status to avoid
expression bias) harbouring detectable L1 retrotransposition events
by PCR. Interestingly, some of the insertions (clones B2, 22, 2, 10, 6
and 5; Table 1) occurred within neuronally expressed genes (see
Supplementary Information). Comparison of the post-integration
sequence with the pre-integration site present in the University
of California Santa Cruz genome database revealed that the
characterized retrotransposition events occurred by conventional
endonuclease-dependent retrotransposition26 (Supplementary
Information). Curiously, clones 2 and 5 contained independent L1
retrotransposition events into the Slc6a6 gene (Table 1). Although
the number of characterized insertions is relatively small, our data
indicate that L1 retrotransposition events can occur in neuronally
expressed genes. The ability of L1 to retrotranspose into genes
is consistent with results from previous studies performed in
transformed cultured cell lines27–29.
Retrotransposition events in NPCs can affect cell fate
In a mixed differentiation protocol (Supplementary Fig. S4a), most
HCN clones harbouring detectable L1 retrotransposition events
had a tendency to differentiate into neurons rather than glial cells
(Table 1). To test whether new L1 retrotransposition events could
influence the phenotype of the NPCs in vitro, we fully characterized
the insertion site present in clone 22 (Cl 22). The L1 was inserted, in
the antisense orientation, into the 5
0
UTR of the rat neuronal
chapsyn110/Psd-93 gene (Fig. 3a). RT–PCR with primers specific
for Psd-93 revealed that RNA levels were about tenfold higher in Cl 22
cells than in the original HCN population. Moreover, Psd-93 was not
overexpressed in Cl 28, which contains two different L1 insertions
(Fig. 3b). The Psd-93 protein level was also 3–5-fold higher in Cl 22,
and the increase in Psd-93 protein level was correlated with a decrease
in Sox2 expression (Fig. 3c).
Table 1 | Analyses of L1 insertions in HCN cell-derived clones
Clone Initial EGFP expression Phenotype Locus L1 insertional target site description
HCN Negative – –
B2 Negative 1q43 Inside olfactory receptor Olr346
3 Positive 2q12 Inside Dhfr-1 (dehidrofolate reductase-1)
28 Positive 6q24 Inside pseudogene similar to human glyceraldehydes-3-phosphate dehydrogenase (G3PDH)
Xq22 Inside Loc317538, similar to dystrophin major muscle isoform
B9 Positive 3q34 150 kb distant from gene similar to brain type ryanodine receptor 3 (RyR3), a Ca2þ release
channel, and 55 kb distant from gene similar to the Notchless WD repeat
22 Positive 1q32 Inside Chapsyn110, postsynaptic protein 93 (Psd-93)
7 Positive 18q12.3 25 kb distant from similar to human G3PDH
2 Positive 4q34 Inside Slc6a6 (solute carrier family 6), neurotransmitter transporter, taurine
F10 Negative n.d. 1q31 2 kb distant from a number of predicted genes with unknown function
9 Negative n.d. 19q11 Inside Loc364967, predicted protein similar to spermatogenesis associated glutamate-rich
protein 4f from Mus musculus
6 Negative 6q16 Inside NVP-3, neural visinin-like Ca2þ-binding protein type 3
5 Positive 4q34 Inside Slc6a6 (solute carrier family 6), neurotransmitter transporter, taurine
26 Positive 2q12 60 kb distant from gene similar to Xrcc4 DSB repair
13 Positive 3p13 20 kb distant from Nidogen 2, a base membrane protein involved in cell adhesion
21 Positive 2q32 50 kb distant from hypothetical kazal type serine protease inhibitor domain, with EF-hand
Ca2þ binding and N-CAM L1 motif
B5 Negative n.d. 19q11 Inside hypothetical protein FLJ10846-like, with unknown function, and 30 kb distant from
CG9882-PA with TPR and ribosomal protein L11 methyltransferase domains
10 Positive 18p11 Inside rCNR gene, a cadherin-related neuronal receptor
1 Positive 7q33 Inside LRTP, similar to mouse testis specific protein with leucine-rich repeat domain and
involved in regulation of protein phosphatases
Phenotypes were determined by exposing the clones to mixed differentiation (RA/FBS) medium, and L1 target sites were determined by inverse PCR (see Methods). Percentages of
oligodendrocytes in these clones were too low to display or nonexistent (data not shown). White, undifferentiated; black, neurons (Map2(a þ b)); grey, astrocytes (Gfap). n.d., not determined.
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We next examined the expression of Psd-93 during neuronal
differentiation. In HCN cells, Psd-93 protein was induced during
the early stages (24 h) of neuronal differentiation, at a similar time as
the retrotransposed EGFP gene was being reactivated and Sox2
was downregulated. Psd-93 protein levels then decreased during
neuronal maturation until they reached a baseline expression level
on day 4 of the assay (Fig. 3d). By comparison, in Cl 22 cells, the
initial level of Psd-93 protein was higher than that observed in HCN
cells and, after differentiation, was induced to a smaller extent than in
HCN cells. However, the downregulation of the Psd-93 protein after
48 h was similar to that observed in HCN cells (Fig. 3d). Thus, despite
its initial overexpression, further regulation of the Psd-93 gene
activity in Cl 22 remained unaffected, indicating that the entire
locus might have been subject to higher-order regulation.
To verify whether the initial overexpression of Psd-93 in
Cl 22 affected neuronal differentiation, we used specific siRNAs to
Figure 3 | L1 retrotransposition events can modify neuronal gene
expression. a, Schematic representation of an L1 insertion into the
Chapsyn110/Psd-93 gene. The primers used in the inversed PCR
experiments are indicated by the green and black arrows. b, RT–PCR showed
that Psd-93 expression is higher in the clone harbouring the L1 insertion in
the Psd-93 gene (Cl 22) than in naive HCN cells, or another cell line
harbouring L1 insertions at different loci (Cl 28). GAPDH, glyceraldehydes-
3-phosphate dehydrogenase. c, Western blot analysis revealed a higher
expression of Psd-93 protein but a lower expression of Sox2 protein in Cl 22
cells than in naive HCN cells. d, Kinetic analysis of Psd-93 expression during
neuronal differentiation. In HCN cells, Psd-93 was upregulated during early
stages of neuronal differentiation (day 1) and then decreased over the course
of the 4-day assay. By comparison, in Cl 22, Psd-93 was expressed initially at
high levels (day 0) and was upregulated to a smaller extent on neuronal
differentiation (day 1). However, the decrease in expression mirrored that
seen in naive HCN cells (days 2–4). As controls, we monitored the







Figure 4 | An L1 retrotransposition event can drive neuronal maturation
through Psd-93 overexpression. a, siRNA against Psd-93 transcripts
(lane 3) results in a 70% decrease in Psd-93 protein levels in Cl 22 cells
(lane 2, without siRNA). Control cells (lane 1) were treated with non-specific
siRNAs. b, Both Cl 22 cells (white bars) and Cl 22 cells treated with irrelevant
siRNAs (black and grey bars) have a tendency to differentiate into neurons
when plated in mixed (RA/FBS) differentiation medium. By comparison,
lower levels of Psd-93 transcripts (stippled bars) attenuated the strong
neuronal bias of Cl 22 cells to that observed in naive HCN cells (hatched
bars) (*P ¼ 0.0056). c, Psd-93 overexpression induced neuronal
differentiation/maturation of HCN cells plated in RA/FBS. The
Psd-93–EGFP fusion protein co-localizes with a neuronal marker (Tuj-1)
but not with an astrocyte marker (Gfap; shown in red). EGFP expression is
shown in green. Co-localization of Psd-93–Egfp and Tuj-1 is shown in the
lower left panel. DAPI, 4,6-diamidino-2-phenylindole. Scale bar, 10 mm.
d, Quantification of panel c. EGFP-positive (fused (black bars) or not (white
bars) with Psd-93) cells were scored for their co-localization with Tuj-1 or
Gfap markers. The percentage of each cell type is indicated on the y axis.
Error bars in all panels show s.e.m.
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transiently downregulate Psd-93 mRNA transcripts (Fig. 4a).
Remarkably, 4 days after electroporation, the resultant Cl 22 cells
seemed less differentiated and showed a decrease in cellular processes
(data not shown), and protein levels more closely resembled those of
naive HCN cells (Fig. 4b). Consistent with this notion was our
observation that overexpression of a Psd-93–egfp fusion protein in
HCN cells was able to induce neuronal differentiation under the
mixed condition RA/FBS (Fig. 4c, d). Together, these observations
indicate that retrotransposition of an engineered human L1 into this
gene can cause an alteration in gene expression, which results in a
phenotypic change in cell behaviour.
L1 somatic retrotransposition in mouse brain
To determine whether L1 retrotransposition can occur in vivo, we
generated a transgenic animal harbouring a retrotransposition-
competent human L1 element (L1RP) under the control of its
endogenous promoter23,30. The EGFP reporter gene is under control
of the CMV promoter; thus, the retrotransposed EGFP gene has the
potential to be expressed ubiquitously in mice. We obtained two
independent founders (Fo4 and Fo6) containing the L1RP/EGFP
transgene. They were bred with wild-type C57BL/6J mice, and the
resultant progeny were screened for L1 retrotransposition events by
genotyping tail DNA with PCR primers flanking the intron present in
the EGFP retrotransposition indicator cassette23. Both founders were
positive for the transgene. Figure 5a is a diagram of the progeny
of Fo4. Animal 1 lacked both the L1RP/EGFP transgene and a
retrotransposed EGFP gene. Animals 2 and 3 contained only the
L1RP/EGFP transgene. Animal 4 lacked the L1RP/EGFP transgene but
contained a retrotransposed EGFP gene. Animal 5 contained both
the L1RP/EGFP transgene and the retrotransposed EGFP gene.
The progeny (a total of seven) containing only the L1RP/EGFP
transgene from both founders (for example animals 2 and 3; Fig. 5a)
were selected for further analysis. We killed adult animals and used
anti-EGFP antibodies to detect L1 retrotransposition events by
immunofluorescence microscopy in tissues from different organs.
EGFP-positive cells were detected in germ cells (ovary and testes,
previously shown to express L1 ORF131) but not in other somatic
tissues (Supplementary Figs S5 and S6). EGFP-positive cells also were
found in the brains of both male and female transgenic animals
(for example striatum, cortex, hypothalamus, hilus, cerebellum,
ventricles, amygdala and hippocampus; Fig. 5c–k). EGFP-positive
cells co-localized only with a neuronal marker (NeuN) and not with
oligodendrocyte (glutathione S-transferase p, GSTp) or astrocyte
(S100-b) markers, indicating that L1 retrotransposition might have
occurred in neuronal precursor cells rather than glial precursor cells
or a common precursor cell early during embryogenesis (Fig. 5i–k).
Because the migration and maturation of the different brain EGFP-
positive cell types occurred in distinct regions in the wild-type brain,
L1 retrotransposition most probably occurred in several distinct
NPCs at different times during brain development.
Analysis of embryos at embryonic day 8.5 (E8.5) showed no
EGFP-positive cells. At this stage the neural tube is already defined
and separated from tissues with the same embryonic origin (such as
the skin). By comparison, EGFP-positive cells were detected in the
Figure 5 | L1 retrotransposition detection in the brains of transgenic
mice. a, Genotyping results on tail DNA from offspring of founder Fo4
(animals 1–5). The PCR primers detected the two possible EGFP
configurations33. Red circles (female) and red squares (male) indicate
animals containing the L1RP/EGFP transgene; shading indicates animals
containing the retrotransposed EGFP gene. b, PCR on genomic DNAs
isolated from laser-captured cells. About 50 cells were collected in each
population (EGFP-positive and EGFP-negative) from the brains of two
animals harbouring the L1RP/EGFP transgene. EGFP-positive cells were
detected in different regions of the mouse brain, such as striatum (c, l)
(white arrows in c indicate EGFP-positive cells), cortex (d), hypothalamus
(k), hilus (e), cerebellum (f), ventricles (g, l, m), amygdala (h) and
hippocampus (i, n). ORF1-positive cells were also found in different regions
of the brain, such as the ventricular zone (l, m) and the dentate gyrus of the
hippocampus (n; white arrows indicate Sox2-positive cells, black arrows
indicate ORF1-positive cells). Scale bar, 10mm.
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cephalic neural tube but not in other regions or organs of the E10.5
embryo. Taken together, these results indicate that L1 retrotransposi-
tion might take place during both embryonic and adult neurogenesis
(Supplementary Fig. S5).
To confirm that the brain cells contained L1 retrotransposition
events, we next isolated EGFP-positive and EGFP-negative cells by
laser-capture microscopy and subjected genomic DNAs extracted
from those cells to PCR analysis (Fig. 5b). EGFP-positive cells
contained both the L1RP/EGFP transgene and the retrotransposed
EGFP gene. Sequence analysis confirmed that the 343-bp PCR
product is the precisely spliced EGFP gene (data not shown).
EGFP-negative cells contained the L1RP/EGFP transgene and a very
faint PCR product corresponding to the spliced EGFP gene. This
faint amplicon might represent silenced EGFP-gene insertions from
mature neurons.
Finally, consistent with the hypothesis that Sox2 acts to repress L1
expression in NSCs and that a decrease in Sox2 expression in NPCs is
correlated with an increase in L1 expression and retrotransposition,
our initial experiments show that anti-Sox2 antibodies do not co-
localize with cells that stain positively with a mouse anti-ORF1p
antibody in Sox2-EGFP transgenic animals32 (Fig. 5l, m) or wild-type
C57BL/6J brain sections (see Fig. 5n, for example).
Discussion
Previous studies have indicated that L1 retrotransposition can occur
in germ cells or in early embryogenesis, before the germ line becomes
a distinct lineage33,34, whereas a cultured cell retrotransposition assay
has revealed that human and mouse L1 elements can retrotranspose
in a variety of transformed or immortalized cultured cell lines22,26,35.
There is only one documented example of a genuine somatic retro-
transposition event in vivo, and it occurred into the adenomatous
polyposis coli gene of a colorectal tumour36. Our data show that rat
NPCs can support retrotransposition of an engineered human
L1 and that a human L1 element can undergo somatic retrotranspo-
sition in the mouse brain. We were unable to detect L1 insertions
in other somatic tissues, indicating that the frequency of L1
retrotransposition might be lower in those tissues than in NPCs.
Two previous reports documented the retrotransposition of an
engineered human L1/EGFP transgene in mice. Ostertag et al.
demonstrated that a human L1 element could retrotranspose in the
male germline before the onset of meiosis II33. However, because the
sperm-specific acrosin promoter drove the expression of the retro-
transposed EGFP gene, it is unlikely that these authors would have
been able to detect the expression of the EGFP protein in the brain.
Prak et al.34 used the same L1RP/EGFP transgene described in this
study, and the authors detected EGFP-positive cells in the testes but
not in the brain or other tissues. However, despite detecting a low
level of EGFP mRNA expression in a variety of different tissues by
RT–PCR34, the authors only analysed EGFP expression directly; they
did not use anti-EGFP antibodies to detect protein expression.
Our expression analyses lead us to propose that L1 retrotranspo-
sons are silenced in NSCs growing in FGF-2 owing to Sox2 repression.
Downregulation of Sox2 triggered by CCg might lead to chromatin
modifications. Indeed, our inability to find overexpressed neuronal
genes in NPCs, coupled with the finding that all the clones selected
for retrotransposition remain multipotent, indicates that L1 can
retrotranspose during early stages of neuronal differentiation.
Our results are consistent with previous analyses that retrotran-
sposition events generated from an engineered human L1 often insert
into genes27–29. Indeed, we found that some L1 retrotransposition
events in NPCs integrated into genes that are expressed in neurons,
whereas other insertions were located in gene ‘deserts’ and/or
repetitive sequences. In one instance, we have shown that retro-
transposition of an engineered human L1 into the Psd-93 gene can
lead to its overexpression, which influences the differentiation
pattern of the NPCs. These data provide proof in principle that new
L1 retrotransposition events can affect the expression of neuronal
genes in vitro. As indicated from previous analyses35,37, we predict
that L1 insertions into genes may also repress their expression or may
lead to alternative splicing patterns38.
Thus, our findings indicate that an engineered human L1 can
retrotranspose in rat NPCs and indicate that individual neurons
might be mosaic with respect to L1 content. Future experiments will
focus on whether endogenous L1s naturally retrotranspose in NPCs
and whether this process has any developmental significance. How-
ever, with those caveats being clearly stated, it is tempting to
speculate that some of the genomic changes necessary for the
uniqueness of individuals within a population, as defined by their
neural circuitry, might be driven, in part, by the activities of mobile
elements.
METHODS
Cell culture and transfection. HCN-A94 and freshly isolated AHNPCs cells
were prepared and cultured as described39. Plasmid transfections were per-
formed with Fugene6 (Roche) for luciferase assay and with a rat NSC nucleo-
fector electroporation kit in all other experiments in accordance with the
manufacturer’s instructions (Amaxa Biosystem).
Luciferase assay and siRNA sequences. Luciferase activity was measured with
the Dual-Luciferase reporter assay system (Promega) in accordance with the
manufacturer’s protocol. The L1 5 0 UTR-Sox2 mutant plasmid was a gift from
J. Athanikar. The Sox2 promoter and complementary DNA were gifts
from A. Rizzino. The Synapsin-1 promoter region was a gift from G. Thiel.
The Psd-93–egfp plasmid was a gift from D. Bredt.
ChIP. The ChIP assay was performed essentially in accordance with the
manufacturer’s protocol with a ChIP assay kit (Upstate) and primers for the
rat L1 5 0 UTR promoter region.
Immunofluorescence and immunoblotting. Immunofluorescence was
performed as described previously40. The mouse polyclonal ORF1 antibody was
a gift from S. L. Martin. Western blotting was performed with standard protocols.
Expression profile analyses. To normalize for processing errors, each replicate
consisted of cells that were plated at the same time from the same starting bulk
population. The following cells were profiled: CCg-responsive cells, neurons and
astrocytes (twenty 96-well plates). The resulting cRNA from each sample was
hybridized to DNA microarrays (Affymetrix Rat Genome RG-U34A). Data
analysis was performed with Affymetrix MAS4.0 software to search for tran-
scripts differentially expressed in CCg-responsive NPCs in comparison with
proliferating bulk progenitors and differentiated cells. The results were analysed
with three different data mining tools: Bullfrog, an empirically based filtering
algorithm41, dChip software for model-based expression analysis42, and Felix
Naef ’s statistically based perfect-match-only algorithm43.
RT–PCR analysis. Total RNA was prepared with an RNAeasy kit (Qiagen). First-
strand cDNA synthesis was performed with the Superscript II kit (Invitrogen).
PCR was performed with Taq polymerase (BMH).
Retrotransposition assays. Antibiotic selection (puromycin, 1mg ml21) was
begun 48 h after electroporation. After 7 days, transfected puromycin-resistant
cells were analysed with a Becton Dickenson FACStar Plus containing a blue
argon laser (488 nm) and fluorescein filter sets (530/30 nm bandpass). The EGFP
PCR primers used here were as described previously23. The L1 retrotransposition
cassettes were gifts from H. H. Kazazian Jr.
Inverse PCR. Genomic DNAs were digested with SspI or XbaI, extracted with
phenol and then chloroform, and subjected to overnight ligation. The products
then were re-extracted, ethanol-precipitated and subjected to first-round
PCR amplification with the primers for the EGFP expression cassette. The L1
pre-integration sequence was identified with Blast (http://www.ncbi.nlm.nih.
gov/BLAST/) and the Celera database (http://www.celeradiscoverysystem.com/).
L1 transgenic animals. Transgenic mice were generated with the standard
pronuclear injection protocol44. The potential founders were screened by PCR
by using primers described previously23. The L1RP/EGFP construct was a gift
from H. H. Kazazian Jr.
Tissue preparation. Animals were killed with an overdose of anaesthetics and
perfused transcardially with 4% paraformaldehyde in phosphate buffer (0.1 M,
pH 7.4). Brains were cut coronally (40mm) on a sliding microtome from a solid-
CO2-cooled block before use.
Other methods. More details can be found in the Supplementary Methods.
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